TBG Diagnostics, formerly known as Progen Pharmaceuticals, has been relisted on the ASX under the code TDL. [ + ]

In his first statement as Australia's Chief Scientist, Dr Alan Finkel AO said he wants to use his new position to "tell Australia's great success stories". [ + ]

Researchers have identified a prognostic biomarker, the neuropeptide pro-NPY, which may help determine the risk of dying from prostate cancer. [ + ]

The Australian Geoscience Council and the Australian Academy of Science have announced the winners of the 34th International Geological Congress Travel Grants, worth $30,000. [ + ]

Researchers have reported a method for making wrinkle-resistant cotton fabrics that is said to be more environmentally friendly and cost-effective than current techniques. [ + ]

The United States Patent and Trademark Office has granted a patent for the IMP731 antibody, owned by Australian biotech company Prima BioMed. [ + ]

Melbourne-based biotech company Sienna Cancer Diagnostics has announced the appointment of Dr John Chiplin to its board of directors. [ + ]

Why does evidence of alien life continue to elude Earth's scientists? Is it because such life never existed at all, or because it has already gone extinct? [ + ]

IRX Therapeutics and ImmunID have entered into a collaboration to predict patients' response to the IRX-2 immunotherapy candidate using the ImmunTraCkeR assay. [ + ]

Professor Ian Chubb has completed his appointment as Australia's seventh Chief Scientist after almost five years in the role. [ + ]

Imugene has announced the extension of its partnership with the Medical University of Vienna to discover and develop new mimotope-based immunotherapies against validated and new oncology targets. [ + ]

Western Australian researchers have discovered that the ability of sea turtles to respond to heat stress varies with their genes. [ + ]

Scientists have discovered that targeting a protein called Hhex could cure acute myeloid leukaemia (AML) in preclinical disease models and could also be a key target for new therapies for human leukaemia. [ + ]

A Swedish research team has developed a way to measure hundreds of proteins in a single blood sample, using these protein patterns to determine the severity of sepsis (blood poisoning) in individual patients.

A Phase 1 clinical trial has gone seriously awry, with one volunteer now dead and others with serious, possibly irreversible, neurological damage. [ + ]